It was just before the COVID-19 pandemic began that Hiroaki Kitano, CEO of Sony AI Inc., found himself in a bunker. In his last trip before the world went into lockdown, Kitano visited the ...

As COVID-19 cases continue to rise, physicians have begun to repurpose existing drugs in an attempt to find something that will help patients get better. In a pilot study at the end of March, 12 ...

The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.

"It's exciting that in collaboration with our clinical colleagues, we can now use AI and machine learning to address medical conditions exacerbated by the COVID pandemic," says Julio Facelli ...